key information
- Location: Millennium Gloucester Hotel & Conference Centre - London Kensington
- Part of the Pharmacovigilance World Tour
- March 8-9, 2023
- 8:30 - 17:30 Local Time
OUR STORY TO TELL THE WORLD
OUR CONFERENCE PROGRAM
This is not just another Drug safety conference. This is a conference which tells you a STORY. One personal experience followed by another, a storyline of exceptional people who happen to choose Drug Safety and Pharmacovigilance as their way to bring needed medicines and protect those who are the most vulnerable, and to improve the health of millions of people on our planet. You will hear experts talk about the current issues in this ever-evolving industry. The best practice case studies on how to integrate new, disruptive technology into the rather rigid processes of PV organization and how it evolves to stay compliant. But how to do this with the more and more restrictive budget? How to prioritize, what methodologies to use for advanced therapies? What is the next evolution step in signal detection noise clearance? Are A.I.-based tools to become our colleagues, helpmates, or our replacement? Nonetheless, each company, department, and project starts with people. But how to build a winning cross-functional team and what kind of workforce is necessary for a drug safety department of the future? What kind of skills to expect from millennials and gen-z entering the industry and why do we need veterans in the industry as well? Challenges with innovations, outsourcing, everchanging regulatory landscape, harmonization, teaching other departments on how to use RWE data, and engaging the more and more aware public. All these topics we address, are conveyed having our mission in our mind, bringing medicines and new therapeutic indications to patients, faster, safer, and more sustainably. Our visionary keynote presentations and best practice case studies will complement engaging panel discussions with different speakers to better understand Pharmacovigilance challenges and solutions from different perspectives, with unique views coming from some of the most experienced and passionate professionals. Our conference will feature numerous assisted formal and informal networking, matchmaking, and breakout sessions to create those critical business friendships that will bring fruitful cooperation and fill that missing piece in our common mission to improve drug safety and quality of life for all.
KEY TOPICS
- Pharmacovigilance of advanced therapies
- Stepping up the global game in PV reporting strategies
- Outcomes of rising public awareness: social media and mobile apps in pharmacovigilance E2B(R3) implementation, are you truly compliant? EudraVigilance and FDA case studies
- Soft skills in world of regulations: interactive workshop
- Creating a talent pool for the next generation of pharmacovigilance- is your job at peril? EMA and NCAs guidance during COVID-19 pandemics and vision in the post-covid era
- Natural Language Processing as a necessary tool in PV reporting
- Navigating PV disruption and skills required to survive
- Struggle to minimize costs with new technology: transfer smarter, not costlier
- The vision of outsourcing in the pharma industry: current and future trends
- Drug safety in oncology: consequences of accelerated approvals in Europe
- An innovative roadmap to the adoption of marketed pharmacovigilance automation and Artificial Intelligence (AI) with a focus on efficiency ROI
- PV audit storytelling session – Inspection insights from a global perspective
- Enhancing PV compliance in a joint partnership for a product marketed in differently regulated markets
Who will attend
- 25% Industry consultants, Academia & Solutions and Software providers
- 75% Big & SME Pharma and Biotech companies
“Great dialogue on key issues. Everyone shared truthful insight and did not hold back, even on negative experiences.”
Sameer Thapar
Assistant Professor & Advisor, Drug Safety and Pharmacovigilance, Rutgers University
“High-quality speakers and attendees, a great mix between healthcare providers, life science companies, providers of digital health & AI solutions, and investors.”
John Mulcahy
CEO, HealthGenuity
“Unlike some other similar events, I found relevance in every session within your conference. The content was neither too simplistic nor too advanced. The participants and presenters provided a diverse view of the issues that are present for most in this industry.”
Christine Clearwater
Manager, Safety Operations and Vendor Management, Baxter, Global Patient Safety
“Loved it. It was very practical and provided valuable insight into practical methods that are actionable for patient safety.”
Daniel Naranjo
Global Safety Lead, Global Patient Safety Evaluation, Takeda
Event Speakers
Henk Streefkerk
Chief Medical Officer
Cell Prothera
Cell Prothera
Petar Gjorgiev
Safety risk Lead & Medical Director
Pfizer
Pfizer
Dimitrios Zampatis
Global Program Safety Lead - Novartis/Sandoz
Mark Duman
Patient engagement specialist
MD Healthcare consultants
MD Healthcare consultants
Erika Barbarosie
Associated Director Compliance
Gilead Sciences
Gilead Sciences
Lionel van Holle
Safety Surveillance Lead at UCB
Tiberius Pereira
Patients for safety
Azza Elgharably
Associate Director, Patient Safety
Operations, Technology and Analytics Astrazeneca
Operations, Technology and Analytics Astrazeneca
Michael von Forstner
Global Head Clinical Safety & Pharmacovigilance
Biogen
Biogen
Nicole Baker
CEO
Biologit
Biologit
Priya Singhal
Head, SVP, Global Safety & Regulatory sciences
Biogen
Biogen
Shikta Das
Associate principal scientist
Astrazeneca
Astrazeneca
Rohan Mane
Director, Safety Risk Management Centre of Excellence
Pfizer
Pfizer
Henk Streefkerk
Chief Medical Officer
Cell Prothera
Cell Prothera
Leonardo Pereira
Clinical Safety Director
Roche
Roche
Sue Rees
Senior Pharmacovigilance lecturer
University of Hertfordshire
University of Hertfordshire
Robert Massouh
Director - Risk Management Product Lead
Pfizer
Pfizer
Zina Sadeq
Director, Regional PV & Alliance Management
Amicus Therapeutics
Amicus Therapeutics
Riti Shah
Medical director of pharmacovigilance
Chiesi
Chiesi
Robert Adams
Global Safety Physician at Reckitt
Marko Korenjak
President
European Liver Patients' Association
European Liver Patients' Association
Emanuel Lohrman
Emanuel Lohrmann at Ostuka pharmaceuticals
Philip Eichorn
Global Head of Drug Safety at Amryt Pharma
Ivana Rosendal
Senior Director, IT Business Partner at Ascendis pharma
Stephanie Tcherny
Global Head of Benefit-Risk Evaluation
Sanofi
Sanofi
View More Speakers
REGISTRATION
Conference
Ticket | March 8-9, 2023
£
2099
-
Access to All Conference Sessions of the 8th Annual Global Pharmacovigilance & RWE Forum - London
-
Access to Post Conference Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits